Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageDebt RatioDebt to EquityEnterprise ValueEquity AverageEquity RatioInterest Coverage RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on EquityTimes Interest Earned

Palisade Bio (PALI) Return on Capital Employed (2016 - 2025)

Palisade Bio has reported Return on Capital Employed over the past 15 years, most recently at 27.35% for Q4 2025.

  • Quarterly Return on Capital Employed rose 18888.0% to 27.35% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 27.35% through Dec 2025, up 18888.0% year-over-year, with the annual reading at 26.56% for FY2025, 13442.0% up from the prior year.
  • Return on Capital Employed was 27.35% for Q4 2025 at Palisade Bio, up from 342.82% in the prior quarter.
  • Over five years, Return on Capital Employed peaked at 27.35% in Q4 2025 and troughed at 830.47% in Q2 2022.
  • The 5-year median for Return on Capital Employed is 174.69% (2022), against an average of 241.7%.
  • Year-over-year, Return on Capital Employed tumbled -43369bps in 2021 and then soared 73076bps in 2023.
  • A 5-year view of Return on Capital Employed shows it stood at 323.63% in 2021, then surged by 63bps to 120.91% in 2022, then rose by 17bps to 100.74% in 2023, then plummeted by -115bps to 216.23% in 2024, then surged by 87bps to 27.35% in 2025.
  • Per Business Quant, the three most recent readings for PALI's Return on Capital Employed are 27.35% (Q4 2025), 342.82% (Q3 2025), and 350.67% (Q2 2025).